一种新的致病性CRB1变体呈现为Leber先天性阿莫罗斯8和基因编辑可行性的评估
Mohamed M Sylla1,2,3, Masha Kolesinkova1,2,3, Bruna Lopes da Costa4
1Department of Ophthalmology, Columbia University Irving Medical Center, New York, NY, USA.
Documenta ophthalmologica. Advances in ophthalmology
|October 7, 2023
概括
勒伯先天性眼膜病 (LCA) 是一种严重的遗传性眼病. 研究人员发现了一种新的CRB1基因变异导致LCA8,为潜在的治疗策略提供了洞察力.
科学领域:
- 眼科医生 眼科 眼科
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 勒伯先天性黄斑症 (LCA) 是一种严重的遗传性视网膜疾病.
- 具体来说,LCA8与克伦布斯同源1 (CRB1) 基因的变异有关.
研究的目的:
- 报告在患有LCA的患者中发现的新型CRB1变异.
- 扩大对导致LCA8.8的CRB1基因变异的理解.
主要方法:
- 一个14岁的男性患有LCA症状的临床病例介绍.
- 眼科成像包括彩色底部摄影,OCT和自发光.
- 全场电网膜学 (ffERG) 用于评估视网膜功能.
- 基因检测用于识别特定的CRB1基因变异.
主要成果:
- 发现了一种新型的同卵性CRB1变体 (c.3057T>A; p.(Tyr1019Ter)).
- 该患者出现了经典的LCA症状和特征性视网膜发现.
- 在 silico 分析中建议了这种变体的潜在主要编辑策略.
结论:
- 鉴定到的CRB1变种很可能是致病性,并导致LCA8.
- 这一发现扩大了已知的致病CRB1变体的范围.
- 这一案例凸显了基因测试在诊断遗传性视网膜疾病方面的重要性.
关键词:
全场电网膜学全场电网膜学基因治疗是一种基因疗法.基因型表型相关性相关性利贝尔先天性黄斑症 (Leber Congenital Amaurosis) 是一种先天性黄斑症.新的CRB1变种主要编辑主要编辑更多相关视频
相关概念视频
CRISPR
52.1K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.1K
CRISPR/Cas9 Genome Editing
27
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
27
What is Genetic Engineering?
74.3K
Overview
74.3K


